Propranolol: here's the fair price
This is what US pharmacies pay, on average, for propranolol. Use it to spot a fair cash price, and feel good about asking for one.
Propranolol 10 Mg Tablet
A fair cash price is usually this cost plus a dispensing fee. If your quote is many times higher, ask about a generic, another pharmacy, or a cash discount.
Ask for generic Propranolol 10 Mg Tablet. Pharmacies pay about $1.39 for 30. Ask your pharmacy for its cash price and compare it with your copay. A fair cash price is close to this cost plus a dispensing fee.
Source: CMS NADAC as of 2026-11-04. Ask your prescriber or pharmacist whether a generic is right for you.
Source: CMS NADAC weekly file as of 2026-11-04. Median across NDCs with the same description. Public domain.
Your ZIP and location stay in your browser. We never store them.
Every strength and form
| Product | Pharmacy cost | 30 count | Effective |
|---|---|---|---|
| PROPRANOLOL 10 MG TABLETGeneric | $0.05 per tablet or capsule | $1.39 | 10/21/2026 |
| PROPRANOLOL 20 MG TABLETGeneric | $0.05 per tablet or capsule | $1.48 | 10/21/2026 |
| PROPRANOLOL 40 MG TABLETGeneric | $0.08 per tablet or capsule | $2.30 | 10/21/2026 |
| PROPRANOLOL 20 MG/5 ML SOLNGeneric | $0.09 per mL | n/a | 10/21/2026 |
| PROPRANOLOL 40 MG/5 ML SOLNGeneric | $0.13 per mL | n/a | 04/22/2026 |
| PROPRANOLOL 80 MG TABLETGeneric | $0.15 per tablet or capsule | $4.64 | 10/21/2026 |
| PROPRANOLOL 60 MG TABLETGeneric | $0.16 per tablet or capsule | $4.71 | 10/21/2026 |
| PROPRANOLOL ER 60 MG CAPSULEGeneric | $0.17 per tablet or capsule | $5.03 | 10/21/2026 |
| PROPRANOLOL ER 80 MG CAPSULEGeneric | $0.18 per tablet or capsule | $5.55 | 10/21/2026 |
| PROPRANOLOL ER 120 MG CAPSULEGeneric | $0.21 per tablet or capsule | $6.18 | 10/21/2026 |
| PROPRANOLOL ER 160 MG CAPSULEGeneric | $0.31 per tablet or capsule | $9.26 | 10/21/2026 |
Source: CMS NADAC, as of 2026-11-04. National average acquisition cost, not a retail quote.
Label basics
What it is used for (FDA label)
INDICATIONS AND USAGE Hypertension Propranolol hydrochloride tablets are indicated in the management of hypertension. It may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. Propranolol hydrochloride is not indicated in the management of hypertensive emergencies. Angina Pectoris Due to Coronary Atherosclerosis Propranolol hydrochloride tablets are indicated to decrease angina frequency and increase exercise tolerance in patients with angina pectoris. Atrial Fibrillation Propranolol hydrochloride tablets are indicated to control ventricular rate in patients with atrial fibrillation and a rapid ventricular response. Myocardial...
Common side effects (FDA label)
ADVERSE REACTIONS The following adverse events were observed and have been reported in patients using propranolol. Cardiovascular Bradycardia; congestive heart failure; intensification of AV block; hypotension; paresthesia of hands; thrombocytopenic purpura; arterial insufficiency, usually of the Raynaud type. Central Nervous System Light-headedness, mental depression manifested by insomnia, lassitude, weakness, fatigue; catatonia; visual disturbances; hallucinations; vivid dreams; an acute reversible syndrome characterized by disorientation for time and place, short-term memory loss,...
Drug interactions (from the label)
Drug Interactions Caution should be exercised when propranolol is administered with drugs that have an effect on CYP2D6, 1A2, or 2C19 metabolic pathways. Co-administration of such drugs with propranolol may lead to clinically relevant drug interactions and changes on its efficacy and/or toxicity (see Drug Interactions in PHARMACOKINETICS AND DRUG METABOLISM ). Cardiovascular Drugs Antiarrhythmics Propafenone has negative inotropic and beta-blocking properties that can be additive to those of propranolol. Quinidine increases the concentration of propranolol and produces greater degrees of clinical beta-blockade and may cause postural hypotension. Amiodarone is an antiarrhythmic agent with...
Warnings (from the label)
WARNINGS Angina Pectoris There have been reports of exacerbation of angina and, in some cases, myocardial infarction, following abrupt discontinuance of propranolol therapy. Therefore, when discontinuance of propranolol is planned, the dosage should be gradually reduced over at least a few weeks and the patient should be cautioned against interruption or cessation of therapy without the physician’s advice. If propranolol therapy is interrupted and exacerbation of angina occurs, it usually is advisable to reinstitute propranolol therapy and take other measures appropriate for the management of angina pectoris. Since coronary artery disease may be unrecognized, it may be prudent to follow the...
Source: FDA drug label via openFDA, label effective 2024-08-09. Full label on DailyMed. Excerpts are verbatim and truncated. Read the full label and ask your pharmacist.